...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on

Sorry to seem pessimistic, but if the abstract does not give the results for eGFR, I think the likelihood is it didn't increase. Authors of abstracts generally want to showcase their most exciting/interesting results - first to get on the program, and then to grab attention during the congress. I cannot think of any reason why they would want to bury such an important outcome. Let's hope I'm wrong!

Share
New Message
Please login to post a reply